Stockreport

NeOnc Technologies Holdings GAAP EPS of -$0.45 [Seeking Alpha]

NeOnc Technologies Holdings, Inc.  (NTHI) 
PDF R&D expenses: $715K vs. $957k in Q3 2024, driven by active management of NEO100 trial sites, recruitment for NEO212, initiation of NEO100-3, and overall patient recruit [Read more]